NIH-funded research R21 grant

How Substance P affects liver injury caused by alcohol

Official title: Regulation of Ductular Reaction by Substance P during Alcohol-induced Liver Injury

Funded at Texas A&m University Health Science Ctr · NIH-10816566 · Data updated 2026-11-12

This study is looking at how a substance in the body called Substance P affects liver problems caused by alcohol, especially how it impacts certain liver cells and their response to injury, with the hope of finding better ways to treat alcohol-related liver disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas A&m University Health Science Ctr
NIH-funded
Lab location1 site (College Station, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$186,865
NIH project number5R21AA030095-02
Project IDNIH-10816566 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from alcohol-associated liver disease, including conditions like alcoholic steatohepatitis and cirrhosis.

Less likely to help

Patients with liver diseases not related to alcohol consumption may not benefit from this research.

What this research studies

This research investigates the role of Substance P, a neuropeptide, in the progression of alcohol-associated liver disease (ALD). It focuses on how alcohol impacts biliary epithelial cells, specifically cholangiocytes, and their response to liver injury. The study aims to understand the mechanisms by which Substance P influences liver inflammation and fibrosis through specific signaling pathways. By examining these interactions, the research seeks to uncover new insights into the treatment of liver diseases related to alcohol consumption.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating alcohol-related liver diseases.

How similar studies have gone: While the role of Substance P in liver injury has been studied, the specific focus on its effects in alcohol-associated liver disease is relatively novel.

Where this research is happening

  • Texas A&m University Health Science Ctr
    College Station, United States
    Active

Researchers

  • Principal investigator: Glaser, Shannon Stroud — Texas A&m University Health Science Ctr
  • Study coordinator: Glaser, Shannon Stroud

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.